Evidence map›Paper›PMID 37597092›Full record

ReviewJournal of nephrology2023

Renal pathology in adult and paediatric population of Japan: review of the Japan renal biopsy registry database from 2007 to 2017.

Kazunori Goto, Takahiro Imaizumi, Riku Hamada, Kenji Ishikura, Tomoki Kosugi, Ichiei Narita, Hitoshi Sugiyama, Akira Shimizu, Hitoshi Yokoyama, Hiroshi Sato and 1 more

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Lupus Nephritis from Pathogenesis to New Therapies: An Update.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 1 country.

Kazunori GotoDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Takahiro ImaizumiDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Riku HamadaDepartment of Nephrology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Kenji IshikuraDepartment of Pediatrics, Kitasato University School of Medicine, Kanagawa, Japan.
Tomoki KosugiDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Ichiei NaritaDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Hitoshi SugiyamaDepartment of Medicine, Kawasaki Medical School General Medical Center, Okayama, Japan.
Akira ShimizuDepartment of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan.
Hitoshi YokoyamaDepartment of Nephrology, Kanazawa Medical University School of Medicine, Ishikawa, Japan.
Hiroshi SatoJR Sendai Hospital, Miyagi, Japan.
Shoichi MauryamaDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. marus@med.nagoya-u.ac.jp.ORCID http://orcid.org/0000-0002-8858-632X
Nagoya University · JPKanazawa Medical University · JPKawasaki Medical School · JPKitasato University · JPNagoya University Hospital · JPNiigata University · JPNippon Medical School · JPSendai Shakai Hoken Hospital · JPTokyo Metropolitan Children's Medical Center · JP

Funding

Childhood-onset, Rare, and Intractable Kidney Diseases in Japan, Research on Rare and Intractable Diseases, Health, Labour and Welfare Sciences Research Grants 20FC1028Japanese Society of Nephrology 20316943
6 · The paper itself

Abstract

backgroundThe Japan Renal Biopsy Registry (J-RBR), a nationwide, web-based, registry system, started in 2007. This study aimed to summarise the epidemiology of biopsy-diagnosed kidney disease in Japan over 10 years.

methodsWe analysed the J-RBR database, from 2007 to 2017. Patients' clinical data collected at the time of biopsy and histopathological diagnoses were used for epidemiological and clinicopathologic analyses.

resultsThe predominant renal biopsy diagnoses were immunoglobulin A nephropathy (39.2%), lupus nephritis (6.5%) and minimal change disease (6.0%) in younger adults (19-64 years), and membranous nephropathy (17.4%), antineutrophil cytoplasmic antibody-associated vasculitis or anti-glomerular basement membrane glomerulonephritis (13.0%), and immunoglobulin A nephropathy (12.5%) in older adults (≥ 65 years). The percentages of patients diagnosed with membranoproliferative glomerulonephritis and immunoglobulin A nephropathy decreased, whereas those with immunoglobulin A vasculitis and diabetic nephropathy increased over the decade. In paediatric patients (< 19 years), immunoglobulin A nephropathy (36.1%), minimal change disease (17.6%), and immunoglobulin A vasculitis (8.6%) were the predominant diagnoses. The percentage of patients diagnosed with immunoglobulin A vasculitis increased over the decade. Based on the sex distribution, minimal change disease and membranous nephropathy were predominant in men aged < 20 and > 40 years, respectively, whereas immunoglobulin A vasculitis and antineutrophil cytoplasmic antibody-associated vasculitis or anti-glomerular basement membrane glomerulonephritis were predominant in women in their 20s and 30s and aged < 50 years, respectively. Immunoglobulin A nephropathy was predominant in men at most ages and in women in their 20s to 40s.

conclusionsThis study describes the distribution and changes in kidney biopsy diagnoses over 10 years in Japan and paves the way for future research on kidney diseases in adults and children.

Indexed as

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGlomerulonephritisGlomerulonephritis, IGAGlomerulonephritis, MembranousIgA VasculitisNephrosis, LipoidAdolescentAdultAgedAntibodies, Antineutrophil CytoplasmicBiopsyChildFemaleHumansImmunoglobulin AJapanAntibodies, Antineutrophil CytoplasmicImmunoglobulin ADisease aetiologyJapan renal biopsy registryKidney biopsyRenal pathology

Identifiers

PMID37597092
PMCPMC10638177
OpenAlexW4386001591

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.